NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.2 Drugs affecting the immune response > 8.2.3 Anti-lymphocyte monoclonal antibodies > Lymphoma (follicular non-Hodgkin's) - rituximab - NICE TAG TA226

Lymphoma (follicular non-Hodgkin's) - rituximab - NICE TAG TA226

1.1 Rituximab maintenance therapy is recommended as an option for the treatment of people with follicular nonHodgkin's lymphoma that has responded to first-line induction therapy with rituximab in combination with chemotherapy.

https://www.nice.org.uk/guidance/TA226

Site by Devopa
© Copyright 2019 NHS. All rights reserved.